Metrics as of 10/15/2026, 06:12 AM (Berlin time), refresh in progress.
AstraZeneca Stock
AstraZeneca PLC
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United Kingdom
- CEO
- Pascal Claude Roland Soriot
- Employees
- 96,100
- Market cap
- £193 B
- IPO
- 21/05/1993
AstraZeneca PLC is a biopharmaceutical company operating in the Healthcare sector as a Drug Manufacturers - General. Headquartered in Cambridge, United Kingdom, the company was originally incorporated in 1992 as Zeneca Group PLC and adopted its current name in April 1999. The company employs 96,100 employees and…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
AstraZeneca stock: price history
1D
-2.0%
1W
+3.7%
1M
+2.6%
6M
-17.7%
YTD
-9.7%
1Y
-0.9%
2Y
+3.5%
5Y
+41.5%
10Y
+148.8%
Next earnings date
Next earnings date
30/10/2026 (in 13 days)
Volatility around earnings
~27% stronger price swings than usual
Ask the agents about AstraZeneca
Analyst assessment of AstraZeneca
1
STRONG BUY
16
BUY
15
HOLD
4
SELL
0
STRONG SELL
36
TOTAL · Buy
As of: 24/09/2023
AstraZeneca stock metrics
P/E
24.72
P/B
5.09
EV/EBITDA
13.92
RETURN ON EQUITY
4.9%
NET MARGIN
16.3%
DEBT/EQUITY
0.64
DIVIDEND YIELD
1.9%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.5%
FLOAT SHARES
1,543,213,980
AVG. DAILY VOLUME (30D)
3,004,787
Dividends
Comparable stocks
Frequently asked questions about AstraZeneca stock
What does AstraZeneca do?
AstraZeneca PLC is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United Kingdom.
The CEO is Pascal Claude Roland Soriot, the company employs around 96,100 people.
The IPO was on 21/05/1993; the stock trades on LSE under the ticker AZN.L.
What do analysts say about AstraZeneca stock?
36 analysts rate the stock, the consensus is Buy (as of 24/09/2023).
This is an external assessment, not a statement by Market Jury.
When does AstraZeneca report next?
The next earnings date is 30/10/2026.
Around past earnings, price swings were roughly 27% stronger than usual.
Does AstraZeneca pay a dividend?
Yes. The last dividend was £79.50 per share, ex-date 06/08/2026, paid on 08/09/2026.
The dividend yield is 1.9% (as of 30/06/2026).
Which stocks are comparable to AstraZeneca?
Comparable stocks include GSK, Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Roche Holding, Amgen and Gilead Sciences.
How can I get AstraZeneca stock analyzed?
Clicking "Analyze stock" lets five strategies assess AstraZeneca against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.